Robert J. Lefkowitz
Member of Scientific Advisory BoardDr. Robert J. Lefkowitz, M.D. is Co-Founder of Septerna, Inc. and serves as its Member of Cross-Functional Scientific and Drug Discovery Advisory Board from December 2022. He has been a Consultant of Lexicon Pharmaceuticals Inc. since March 2003. Dr. Lefkowitz serves as Strategic Advisor of Proventys, Inc. Dr. Lefkowitz has been Scientific Founder at Xsira Pharmaceuticals, Inc. since 1999 and serves as its Consultant. He served as Consultant of Trevena, Inc. and was its Scientific Founder. He is the James B. Duke Professor of Medicine (since 1982), Professor of Biochemistry and Chemistry and a Howard Hughes Medical Institute Investigator (since 1976) at Duke University Medical Center, where he has served on the faculty since 1973. In 1977, he was promoted to Professor of Medicine at Duke University. Upon completing this training in 1973, he was appointed Associate Professor of Medicine at the Duke University Medical Center. His research is concerned with the molecular properties and regulatory mechanisms that control the function of plasma membrane receptors for hormones and drugs under normal and pathological circumstances. Dr. Lefkowitz has made seminal discoveries in elucidating the key components of cellular signal transduction, resulting in being the most highly cited scientist in the world in the field of Biology and Biochemistry for the period from 1992 to 2002, as determined by the ISI Essential Science Indicators. From 1970 to 1973, he was with Massachusetts General Hospital. After serving an internship and one year of general medical residency at the College of Physicians and Surgeons, he served as a Clinical and Research Associate at the National Institutes of Health from 1968 to 1970. He served as a Member of Scientific Resource Board at Genentech, Inc. Dr. Lefkowitz had been an Independent Director of Lexicon Pharmaceuticals, Inc. since February 2001 until November 2024. He serves as a Member of Scientific Advisory Board at Five prime Therapeutics, Inc. and Trevena, Inc. He serves as Member of Scientific Advisory Board at Nuevolution AB (publ). He was an Established investigator of the American Heart Association from 1973 to 1976. His other many awards include the Institut de France Foundation Lefoulon-Delalande Grand Prix for Science Award, the Robert J. and Claire Pasarow Foundation Award for Cardiovascular Research and the Jessie Stevenson Kovalenko Medal from the National Academy of Sciences. Dr. Lefkowitz received more than 50 major awards for his research, including the 2012 Nobel Prize in Chemistry for his research within the field of G-protein-coupled receptors by The Royal Swedish Academy of Sciences, the Shaw Prize, the Albany Medical Center Prize and the 2007 National Medal of Science. Dr. Lefkowitz has served on the editorial boards of ten leading journals in the fields of biochemistry, pharmacology and clinical investigation and as the president of the American Society for Clinical Investigation. He has published over 600 articles, authored or co-authored three books including the seventh edition of the Principles of Biochemistry. Dr. Lefkowitz has received numerous awards for his excellence in cardiovascular research. These awards include: The John J. Able Award in Pharmacology from the American Society for Pharmacology and Experimental Therapeutics (1978), the George W. Thorn Award for Scientific Excellence of the Howard Hughes Medical Institute (1979), the Ernst Oppenheimer Memorial Award of the Endocrine Society (1982), the Lita Annenberg Hazen Award for Excellence in Clinical Research (1983), the Goodman and Gilman Award of the American Society for Pharmacology and Experimental Therapeutics (1986), the North Carolina Award for Science (1987), the Gairdner Foundation International Award (1988), Novo Nordisk Biotechnology Award (1990), City of Medicine Award with Alfred Gilman and Phillip Leder, Durham, N.C. (1992), Bristol-Myers Squibb Award for Distinguished Achievement in Cardiovascular Research (1992) and the Ciba Award for Hypertension Research (1996). Dr. Lefkowitz is also a member of the National Academy of Sciences, the American Academy of Arts and Sciences and the Institute of Medicine of the National Academy of Sciences. Dr. Lefkowitz completed his medical residency and research and clinical training in cardiovascular disease at Massachusetts General Hospital. He carried out postgraduate research at the National Institutes of Health and Harvard Medical School. He received his B.A. in chemistry from Columbia University in 1962 and his M.D. from Edward S. Harkness Eye Institute, Columbia University College of Physicians and Surgeons in 1966.
Positions
- Company NameTrevena, Inc.Stock CodeTRVNPositionMember of Scientific Advisory BoardColleagues
- CLCarrie L. BourdowPresident, CEO & Chairman
- MAMark A. DemitrackSenior VP & Chief Medical Officer
- HAHoward A. RockmanScientific Founder, Consultant and Member of Scientific Advisory Board
- KSKatrine SuttonPrincipal Financial Officer & principal accounting officer
- RTRobert T. YoderSenior VP, Chief Business Officer, Head of Commercial Operations & Chief Compliance Officer
- BYBarbara YanniIndependent Director
- RJRobert J. LefkowitzMember of Scientific Advisory Board
- JLJohn L. LaMattinaMember of the Scientific Advisory Board
- Company NameSepterna, Inc.Stock CodeSEPNPositionCo-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory BoardColleagues
- JTJeffrey T. FinerCo-Founder, CEO & Director
- JKJeffrey K. TongChairman of the Board
- EPElizabeth P. BhattPresident & COO
- GMGilbert M. LabrucherieChief Financial Officer
- ACArthur ChristopoulosCo-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
- PSPatrick SextonCo-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
